Search results
COVID-19: What to know about the new variants; what are the symptoms of FLiRT?
FOX 25 Boston· 1 day agoA new group of COVID-19 variants are sparking concerns about a potential flare-up of the virus over...
COVID-19 variants called FLiRT are spreading across US
FOX 29 Philadelphia· 19 hours agoA new group of COVID-19 variants is circulating across the United States. According to tracking by...
American Journal of Preventive Medicine Study Finds COVID-19 Vaccination Public Education Campaign...
Sierra Sun Times· 1 hour agoThe U.S. Department of Health and Human Services’ (HHS) COVID-19 Vaccination Public Education...
New COVID-19 ‘FLiRT’ variants could mean a summer surge
WPIX New York City, NY via Yahoo News· 5 hours ago(NewsNation) — Two new COVID-19 variants are circulating, and they have the potential to evade...
New COVID-19 'FLiRT' variants could mean a summer surge. Here's what you need to know
WJHL· 14 hours agoSymptoms of the latest COVID strains are similar to earlier versions, including fever, chills and...
The true tragedy of the Covid-19 vaccines
The Telegraph via Yahoo News· 6 days agoVaccination is one of mankind’s most miraculous innovations. The eradication of smallpox, and the retreat of measles and other cruel afflictions, mean...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 5 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 23 hours agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Here’s what local experts are saying about new COVID-19 variants
WPXI· 5 hours agoAt a time when new COVID-19 infections are considered low, new variations, called FLiRT variants,...
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational...
WKRN Nashville· 1 hour agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its first quarter 2024 financial ...